SCHEMBL22360431

SCHEMBL22360431

C=CC1Nc2ccccc2SC1C=C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.47
RAB9A P51151 1/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
BRD4 O60885 1/20 0.36
CREBBP Q92793 1/20 0.36
NPC1 O15118 1/20 0.33
POLB P06746 2/20 0.32
ALOX15 P16050 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
CYP1A2 P05177 1/20 0.32
BCHE P06276 1/20 0.32
CYP3A4 P08684 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
ALOX12 P18054 1/20 0.32
MAOA P21397 1/20 0.32
CNR1 P21554 1/20 0.32
ACHE P22303 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28820828 0.71 IDO1 (0.47) IDO1RAB9AMEN1KMT2ABRD4
SCHEMBL21808704 0.68 IDO1 (0.61) IDO1RAB9AMEN1KMT2ABRD4
SCHEMBL27355088 0.67 IDO1 (0.46) IDO1RAB9AMEN1KMT2ABRD4
SCHEMBL27759204 0.65 IDO1 (0.43) IDO1RAB9AMEN1KMT2ABRD4
SCHEMBL11539110 0.65 IDO1 (0.57) IDO1RAB9AMEN1KMT2ABRD4
SCHEMBL11502327 0.65 IDO1 (0.57) IDO1RAB9AMEN1KMT2ABRD4
SCHEMBL12661831 0.65 IDO1 (0.57) IDO1RAB9AMEN1KMT2ABRD4
SCHEMBL16711400 0.65 IDO1 (0.57) IDO1RAB9AMEN1KMT2ABRD4
SCHEMBL338205 0.65 IDO1 (0.57) IDO1RAB9AMEN1KMT2ABRD4
SCHEMBL1754221 0.65 IDO1 (0.57) IDO1RAB9AMEN1KMT2ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542258-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-01-03 US disclosed
US-20200262825-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2020-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200262825-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 IDO1 541/4885RAB9A 1986/4885MEN1 316/4885
US-11542258-B2 Heterocyclic compound and organic light emitting device comprising the same CYP1A1, CRY1, CYP1B1 IDO1 698/4885RAB9A 2321/4885MEN1 451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.